News March 28, 2022
Dr. Seidel has more than 20 years of experience in the medical device industry BURLINGTON, Mass. and...
News March 15, 2022
BURLINGTON, Mass. and JERUSALEM, March 15, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News March 9, 2022
Revenue Growth of 34% in 2021, with Record Quarterly and Annual Revenues Continued Progress in Expanding...
News March 1, 2022
BURLINGTON, Mass. and JERUSALEM, March 01, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News February 28, 2022
BURLINGTON, Mass. and JERUSALEM, Feb. 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News February 23, 2022
Results Distinguish Deep TMS as More Effective in Subjects with Higher Anxiety Symptoms, Long Considered...
News February 1, 2022
BURLINGTON, Mass. and JERUSALEM, February 1, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News January 31, 2022
Palmetto GBA Covers Medicare Patients in Seven States BURLINGTON, Mass. and JERUSALEM, January 31, 2022...
News January 26, 2022
World-Renowned Specialist in Addiction and Anxiety Treatment Joins Premier Group of Researchers and Clinicians...
News January 12, 2022
Positive Data Support the Durability and Cost-Effectiveness of Deep TMS as a Treatment for Obsessive-Compulsive...
News December 9, 2021
Randomized, Placebo-Controlled, Double-Blind Pilot Study Evaluated Deep TMS Treatment in Reducing Alcohol...
News November 30, 2021
BURLINGTON, Mass. and JERUSALEM, November 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...
News November 17, 2021
Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System...
News November 3, 2021
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News October 12, 2021
Zafiris Daskalakis, MD, PhD to Bring Extensive Research and Clinical Expertise to Assist in Guiding Growth...
News September 30, 2021
Evidence Supports Use of Deep TMS as a Safe and Effective Treatment for Smoking Addiction BURLINGTON,...
News September 9, 2021
BURLINGTON, Mass. and JERUSALEM, Sept. 09, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News August 30, 2021
BURLINGTON, Mass. and JERUSALEM, August 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...